Cytoprotection against beta-amyloid (Aβ) peptide-mediated oxidative damage and autophagy by Keap1 RNAi in human glioma U87mg cells

Neuroscience Research

Volumn 94, Issue , 2015, Pages 70-78

  Youn, Pilju ^a   Chen, Yizhe ^a   Furgeson, Darin Y ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Autophagy; Beta amyloid (A ) peptide; Keap1 Nrf2 pathway; Neurodegenerative disorders (NDD); Oxidative stress; RNA interference (RNAi)

Indexed keywords

AMYLOID BETA PROTEIN; HYDROGEN PEROXIDE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; SMALL INTERFERING RNA; AMYLOID BETA-PROTEIN (1-42); CHOLECYSTOKININ OCTAPEPTIDE; COPPER ZINC SUPEROXIDE DISMUTASE; KEAP1 PROTEIN, HUMAN; MALONALDEHYDE; MESSENGER RNA; NFE2L2 PROTEIN, HUMAN; NQO1 PROTEIN, HUMAN; OXIDIZING AGENT; PEPTIDE FRAGMENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SIGNAL PEPTIDE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2;

ANTIOXIDANT ACTIVITY; ARTICLE; AUTOPHAGY; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; GENE EXPRESSION; GLIOMA CELL; HUMAN; HUMAN CELL; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RNA INTERFERENCE; UPREGULATION; ANALYSIS OF VARIANCE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; AUTOPHAGY; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; HYDROGEN PEROXIDE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALONDIALDEHYDE; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; OXIDANTS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SINCALIDE; SUPEROXIDE DISMUTASE;

EID: 84927912966     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2014.12.015     Document Type: Article

References (33)

1. Alzheimer's Association Alzheimer's disease facts and figures. Alzheimers Dement. 2013, 9:208-245.
2. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat. Rev. Neurosci. 2004, 5:S18-S25.
3. Barnham K.J., Masters C.L., Bush A.I. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 2004, 3:205-214.
4. Behl C., Davis J., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 1994, 77:817-827.
5. Boudreau R.L., Rodríguez-Lebrón E., Davidson B.L. RNAi medicine for the brain: progresses and challenges. Hum. Mol. Genet. 2011, 20:R21-R27.
6. Calkins M.J., Johnson D.A., Townsend J.A., Vargas M.R., Dowell J.A., Williamson T.P., Kraft A.D., Lee J.M., Li J., Johnson J.A. The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid. Redox Signal. 2009, 11:497-508.
7. Chen Y., McMillan-Ward E., Kong J., Israels S., Gibson S. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ. 2008, 15:171-182.
8. de Vries H.E., Witte M., Hondius D., Rozemuller A.J.M., Drukarch B., Hoozemans J., van Horssen J. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?. Free Radic. Biol. Med. 2008, 45:1375-1383.
9. Devling T.W., Lindsay C.D., McLellan L.I., McMahon M., Hayes J.D. Utility of siRNA against Keap1 as a strategy to stimulate a cancer chemopreventive phenotype. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:7280-7285.
10. Drake J., Link C.D., Butterfield D.A. Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid β-peptide (1-42) in a transgenic Caenorhabditis elegans model. Neurobiol. Aging 2003, 24:415-420.
11. Dyrks T., Dyrks E., Hartmann T., Masters C., Beyreuther K. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 1992, 267:18210-18217.
12. Dysken M.W., Sano M., Asthana S., Vertrees J.E., Pallaki M., Llorente M., Love S., Schellenberg G.D., McCarten J.R., Malphurs J. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. J. Am. Med. Assoc. 2014, 311:33-44.
13. Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., Yokoyama M., Mishima K., Saito I., Okano H. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006, 441:885-889.
14. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
15. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 1997, 236:313-322.
16. Jung K.A., Kwak M.K. Enhanced 4-hydroxynonenal resistance in KEAP1 silenced human colon cancer cells. Oxid. Med. Cell. Longev. 2013, 2013. Article ID 423965.
17. Kabeya Y., Mizushima N., Ueno T., Yamamoto A., Kirisako T., Noda T., Kominami E., Ohsumi Y., Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000, 19:5720-5728.
18. Kobayashi A., Kang M.-I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., Igarashi K., Yamamoto M. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 2004, 24:7130-7139.
19. Li W., Yu S.-W., Kong A.-N.T. Nrf2 possesses a redox-sensitive nuclear exporting signal in the Neh5 transactivation domain. J. Biol. Chem. 2006, 281:27251-27263.
20. Melo A., Monteiro L., Lima R.M.F., de Cerqueira M.D. Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives. Oxid. Med. Cell. Longev. 2011, 2011. Article ID 467180.
21. Miller E.R., Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 2005, 142:37-46.
22. Mizushima N., Yoshimori T. How to interpret LC3 immunoblotting. Autophagy 2007, 3:542.
23. Mortimore G.E., Schworer C.M. Induction of autophagy by amino-acid deprivation in perfused rat liver. Nature 1977, 270:176.
24. Nixon R.A., Wegiel J., Kumar A., Yu W.H., Peterhoff C., Cataldo A., Cuervo A.M. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J. Neuropathol. Exp. Neurol. 2005, 64:113-122.
25. Ramsey C.P., Glass C.A., Montgomery M.B., Lindl K.A., Ritson G.P., Chia L.A., Hamilton R.L., Chu C.T., Jordan-Sciutto K.L. Expression of Nrf2 in neurodegenerative diseases. J. Neuropathol. Exp. Neurol. 2007, 66:75-85.
26. Salloway S., Sperling R., Fox N.C., Blennow K., Klunk W., Raskind M., Sabbagh M., Honig L.S., Porsteinsson A.P., Ferris S. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N. Engl. J. Med. 2014, 370:322-333.
27. Sung S., Yao Y., Uryu K., Yang H., Lee V.M., Trojanowski J.Q., Praticò D. Early vitamin E supplementation in young but not aged mice reduces Aβ levels and amyloid deposition in a transgenic model of Alzheimer's disease. FASEB J. 2004, 18:323-325.
28. Wakabayashi N., Itoh K., Wakabayashi J., Motohashi H., Noda S., Takahashi S., Imakado S., Kotsuji T., Otsuka F., Roop D.R. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 2003, 35:238-245.
29. Wang H., Ma J., Tan Y., Wang Z., Sheng C., Chen S., Ding J. Amyloid-β 1-42 induces reactive oxygen species-mediated autophagic cell death in U87 and SH-SY5Y cells. J. Alzheimers Dis. 2010, 21:597-610.
30. Yatin S., Varadarajan S., Link C., Butterfield D. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid ß-peptide (1-42). Neurobiol. Aging 1999, 20:325-330.
31. Youn P., Chen Y., Furgeson D.Y. A myristoylated cell-penetrating peptide bearing a transferrin receptor-targeting sequence for neuro-targeted siRNA delivery. Mol. Pharm. 2014, 11:486-495.
32. Yu W.H., Cuervo A.M., Kumar A., Peterhoff C.M., Schmidt S.D., Lee J.-H., Mohan P.S., Mercken M., Farmery M.R., Tjernberg L.O. Macroautophagy-a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease. J. Cell Biol. 2005, 171:87-98.
33. Zhang H., Kong X., Kang J., Su J., Li Y., Zhong J., Sun L. Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells. Toxicol. Sci. 2009, 110:376-388.